Table 1.
Baseline characteristics
| Low-dose group (n=14) | High-dose group (n=12) | All participants*(n=26) | Control group (n=6) | ||
|---|---|---|---|---|---|
| Sex | |||||
| Female | 10 (71%) | 10 (83%) | 20 (77%) | 4 (67%) | |
| Male | 4 (29%) | 2 (17%) | 6 (23%) | 2 (33%) | |
| Age, years | 28·7 (8·4; 18–47) | 30·8 (8·7; 21–52) | 29·7 (8·4; 18–52) | 35·0 (5·1; 27–40) | |
| Ethnicity | |||||
| White | 12 (86%) | 10 (83%) | 22 (85%) | 5 (83%) | |
| Black or African American | 1 (7%) | 0 | 1 (4%) | 0 | |
| Native Hawaiian or Pacific Islander | 0 | 1 (8%) | 1 (4%) | 0 | |
| Hispanic or Latino | 1 (7%) | 1 (8%) | 2 (8%) | 0 | |
| American Indian or Alaska Native | 0 | 0 | 0 | 0 | |
| Asian | 0 | 0 | 0 | 1 (17%) | |
| BMI, kg/m2 | 23·6 (2·5) | 23·5 (3·7) | 23·6 (3·0) | 22·9 (1·2) | |
Data are mean (SD; range), n (%), or mean (SD). BMI=body-mass index.
*
Except for the control group.